250 mcg bpc 157 BPC-157 (Capsules) bpc-157 rapid - 250mcg 5-amino-1mq

Testing: Third-party lab report available where provided

Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant

It also promotes the formation of new blood vessels, a process called angiogenesis, which improves the delivery of oxygen and nutrients to damaged tissues, further speeding up recovery

Clinical weight loss outcomes The landmark STEP clinical trials established the efficacy of semaglutide 2.4 mg for weight management

Clean Discharge from the hydro-cyclones, is sent to the Holding Tank